echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Taizhou Pharmaceutical High-tech Zone with the "4-3-1" characteristic industrial system, to create new advantages in development

    Taizhou Pharmaceutical High-tech Zone with the "4-3-1" characteristic industrial system, to create new advantages in development

    • Last Update: 2020-06-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pharmaceutical Network Pharmaceutical Engineering Recently, the Jiangsu provincial government issued a circular to the province in 2019 to promote the relevant major policy measures to really work hard, to achieve significant results of the local inspection incentivesTaizhou Pharmaceutical High-tech Zone is listed for "vigorously cultivating strategic emerging industries, obvious advantages of industrial characteristics, strong technological innovation ability, strong industrial base" and the list. Taizhou Pharmaceutical High-tech Zone by virtue of "high-tech strong", increase the development of new advantages Specifically, the current Taizhou Pharmaceutical High-tech Zone has gathered more than 1000 domestic and foreign pharmaceutical enterprises, including AstraZeneca, Takeda Pharmaceutical, Bollinger Ingehan and other 13 world-renowned multinational pharmaceutical enterprises, Haiwang Group, Shi Pharma Group, MaboTek, Changtai Pharmaceutical and other well-known domestic pharmaceutical enterprises have joined.
    It is understood that the Longxiang Pharmaceutical Taizhou Co, Ltdproject, is by India's second largest pharmaceutical listed enterpriseSabindo Pharmaceutical Co., Ltdinvestment, a total investment of 200 million U.Sdollars, the main construction of sterile preparation production workshop and supporting the construction of office, quality inspection, warehousing, power, environmental protection and other auxiliary facilities, after the completion of the year can produce injections about 200 million (bottles), annual output value of about 1.6 billion yuan, the realization of profits and taxes 538 million yuan, products sold to the United States, the European Union market.
    In addition, Taizhou Pharmaceutical High-tech Zone also gathered more than 4000 high-level talents, including 2 Nobel Laureates were hired as China Pharmaceutical City Development Consultants, 1 National Science and Technology Award winner, 8 academicians and so on.
    From the above, it can be seen that Taizhou Pharmaceutical High-tech Zone in the collection of high-end industries, high-end enterprises, high-end products, high-end talent;
    In fact, all along, Taizhou Pharmaceutical High-tech Zone has been adhering to the characteristic development, the current focus around the "four three-chain" overall thinking, has built a "4-3-1" characteristic industry system, that is, focus on the development of biological drugs, chemical drugs new formulations, in vitro diagnostic reagents and high-end medical equipment, Chinese medicine modernization of the four pillar industries, to enhance the development of special medical formula food, medical equipment and new materials, animal health drugs three characteristics of the industry, and vigorously develop the development of precision health services industry, Second start-up and then start.
    Under the guidance of this line of thinking, as of March 12, Taizhou Pharmaceutical High-tech Zone has concentrated on 10 projects, with a total planned investment of 11.56 billion yuan, including taizhou International Precision Health Center's clinical application platform, incubation base, health care base, commercial support and other key projects; These large-scale investment, the average single project investment scale of more than 500 million yuan of projects, just with the Taizhou Pharmaceutical High-tech Zone, "4 plus 3-1" characteristic sepsis industry system to match.
    According to the author's understanding, at present, Taizhou Pharmaceutical High-tech Zone is in accordance with the characteristics of the pharmaceutical industry and professional requirements, to build and continuously optimize the development of the pharmaceutical industry to adapt to the convenient drug registration service system, thoughtful high-end talent service system, a sound public service platform system, a safe intellectual property protection system ..All these will provide a perfect and effective guarantee for the medical enterprises in the park to accelerate their development and seize the opportunity.
    In general, with the development of the pharmaceutical industry, the establishment of many high-tech pharmaceutical fields, the establishment of these high-tech zones can not only further integrate local medical resources, but also accelerate the development of the pharmaceutical industryIn the future, Taizhou Pharmaceutical High-tech Zone, in accordance with the current development trend, will certainly make more achievements in the future, while contributing more strength to the development of the domestic pharmaceutical industry.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.